Utility of Topical Estoriol on the Nasal Mucosa in a Patient with Osler Disease

Utility of Topical Estoriol on the Nasal Mucosa in a Patient with Osler Disease - Utility of Topical Estoriol on the Nasal Mucoza in Patient witn Osler's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017827

Enrollment

100

Registered

2015-06-05

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osler&#39

Interventions

estoriol ointment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: nasal bleeding

Exclusion criteria

Exclusion criteria: Patients judged inappropriate for this study

Design outcomes

Primary

Measure	Time frame
Assesment of symptom after as below for the Osler's disesase. Osler's disease patients use Estoriol ointoment. Assesment:medical examination at the department of otorhinolaryngology with a disease questionnarie.	—

Secondary

Measure	Time frame
After 3 motnths from treatment,we check serum estriol. Assesment:serum estriol	—

Countries

Japan

Contacts

Public ContactKen-ichi Nibu

Kobe Universuty Graduate Shool of Medicine Department of otorhinolaryngology head and Neck Surgery

nibu@med.kobe-u.ac.jp81-78-382-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026